5.2(top 5%)
2-year impact
5.2(top 5%)
3-year impact
5.0(top 5%)
5-year impact
4.5(top 5%)
10-year impact
4.2K(top 5%)
PR articles
142.1K(top 5%)
PR citations
141(top 2%)
PR h-index
154(top 2%)
h-index
5.6(top 5%)
extended IF
4.2(top 5%)
2-YI (article-only)
6.4(top 50%)
2-YI (review-only)
5.2(top 5%)
2-YI (no self-cite.)
4.5K
documents
171.8K
doc citations

Top Articles

#TitleJournalYearPR Citations
1Epidermal growth factor-related peptides and their receptors in human malignanciesCritical Reviews in Oncology/Hematology19951,946
2The cellular and molecular basis of hyperthermiaCritical Reviews in Oncology/Hematology20021,272
3The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancerCritical Reviews in Oncology/Hematology20131,228
4Nickel essentiality, toxicity, and carcinogenicityCritical Reviews in Oncology/Hematology2002874
5Use of comprehensive geriatric assessment in older cancer patients:Critical Reviews in Oncology/Hematology2005804
6The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophagesCritical Reviews in Oncology/Hematology2008801
7Employment and work-related issues in cancer survivorsCritical Reviews in Oncology/Hematology2011615
8Vanadium in cancer treatmentCritical Reviews in Oncology/Hematology2002523
9Mechanisms of resistance to cisplatin and carboplatinCritical Reviews in Oncology/Hematology2007499
10Cathepsin D—Many functions of one aspartic proteaseCritical Reviews in Oncology/Hematology2008498
11Vascular endothelial growth factor (VEGF) signaling in tumor progressionCritical Reviews in Oncology/Hematology2007464
12Stem cell origin of cancer and differentiation therapyCritical Reviews in Oncology/Hematology2004420
13TIMPs as multifacial proteinsCritical Reviews in Oncology/Hematology2004413
14The Wnt signaling pathway in cancerCritical Reviews in Oncology/Hematology2016412
15Chemotherapy-induced peripheral neurotoxicity (CIPN): An updateCritical Reviews in Oncology/Hematology2012407
16Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectivesCritical Reviews in Oncology/Hematology2021400
17Exploring miRNA based approaches in cancer diagnostics and therapeuticsCritical Reviews in Oncology/Hematology2016377
18Major and minor salivary gland tumorsCritical Reviews in Oncology/Hematology2010370
19Circulating microRNAs: Association with disease and potential use as biomarkersCritical Reviews in Oncology/Hematology2011367
20Use of ?-asparaginase in childhood ALLCritical Reviews in Oncology/Hematology1998359
21Regulation of angiogenesis by hypoxia-inducible factor 1Critical Reviews in Oncology/Hematology2006354
22Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapyCritical Reviews in Oncology/Hematology2001345
23Radiation-associated cardiovascular diseaseCritical Reviews in Oncology/Hematology2003345
24Colon cancerCritical Reviews in Oncology/Hematology2010341
25Gastric cancerCritical Reviews in Oncology/Hematology2009323
26Diffuse large B-cell lymphomaCritical Reviews in Oncology/Hematology2013323
27Associations of social networks with cancer mortality: A meta-analysisCritical Reviews in Oncology/Hematology2010320
28E-cadherin: Its dysregulation in carcinogenesis and clinical implicationsCritical Reviews in Oncology/Hematology2018319
29Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: A prospective observational cohort studyCritical Reviews in Oncology/Hematology2010316
30Particular aspects of platinum compounds used at present in cancer treatmentCritical Reviews in Oncology/Hematology2002310
31Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacyCritical Reviews in Oncology/Hematology2005310
32Multicellular resistance: a paradigm for clinical resistance?Critical Reviews in Oncology/Hematology2000309
33MeningiomaCritical Reviews in Oncology/Hematology2008301
34Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can helpCritical Reviews in Oncology/Hematology2008298
35Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancerCritical Reviews in Oncology/Hematology2019298
36PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysisCritical Reviews in Oncology/Hematology2016297
37The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemiaCritical Reviews in Oncology/Hematology2004295
38Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantationCritical Reviews in Oncology/Hematology2005295
39Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approachCritical Reviews in Oncology/Hematology2005293
40Characteristics of gastric cancer around the worldCritical Reviews in Oncology/Hematology2023288
41On the dual roles and polarized phenotypes of neutrophils in tumor development and progressionCritical Reviews in Oncology/Hematology2012281
42Copper and carcinogenesisCritical Reviews in Oncology/Hematology2002278
43Nutritional support of the cancer patient: issues and dilemmasCritical Reviews in Oncology/Hematology2000277
44A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumorsCritical Reviews in Oncology/Hematology2018276
45Recognition and processing of cisplatin- and oxaliplatin-DNA adductsCritical Reviews in Oncology/Hematology2005275
46Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemiaCritical Reviews in Oncology/Hematology2007270
47The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta -analysisCritical Reviews in Oncology/Hematology2017270
48Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasionCritical Reviews in Oncology/Hematology2004267
49A potential role of macrophage activation in the treatment of cancerCritical Reviews in Oncology/Hematology2002266
50Myosteatosis and prognosis in cancer: Systematic review and meta-analysisCritical Reviews in Oncology/Hematology2020259